These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Autophagy-related protein 7 deficiency in amyloid β (Aβ) precursor protein transgenic mice decreases Aβ in the multivesicular bodies and induces Aβ accumulation in the Golgi. Nilsson P; Sekiguchi M; Akagi T; Izumi S; Komori T; Hui K; Sörgjerd K; Tanaka M; Saito T; Iwata N; Saido TC Am J Pathol; 2015 Feb; 185(2):305-13. PubMed ID: 25433221 [TBL] [Abstract][Full Text] [Related]
5. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice. Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478 [TBL] [Abstract][Full Text] [Related]
6. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model. Ohno M; Hiraoka Y; Lichtenthaler SF; Nishi K; Saijo S; Matsuoka T; Tomimoto H; Araki W; Takahashi R; Kita T; Kimura T; Nishi E Neurobiol Aging; 2014 Jan; 35(1):213-22. PubMed ID: 23954170 [TBL] [Abstract][Full Text] [Related]
7. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease. van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007 [TBL] [Abstract][Full Text] [Related]
8. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation. Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077 [TBL] [Abstract][Full Text] [Related]
9. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease. Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982 [TBL] [Abstract][Full Text] [Related]
10. Tau deletion impairs intracellular β-amyloid-42 clearance and leads to more extracellular plaque deposition in gene transfer models. Lonskaya I; Hebron M; Chen W; Schachter J; Moussa C Mol Neurodegener; 2014 Nov; 9():46. PubMed ID: 25384392 [TBL] [Abstract][Full Text] [Related]
11. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075 [TBL] [Abstract][Full Text] [Related]
12. Intraneuronal Aβ as a trigger for neuron loss: can this be translated into human pathology? Bayer TA; Wirths O Biochem Soc Trans; 2011 Aug; 39(4):857-61. PubMed ID: 21787313 [TBL] [Abstract][Full Text] [Related]
13. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model. Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596 [TBL] [Abstract][Full Text] [Related]
14. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease. Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161 [TBL] [Abstract][Full Text] [Related]
15. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice. Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708 [TBL] [Abstract][Full Text] [Related]
16. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis. Crews L; Rockenstein E; Masliah E Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183 [TBL] [Abstract][Full Text] [Related]
18. Immunogold labeling and X-ray fluorescence microscopy reveal enrichment ratios of Cu and Zn, metabolism of APP and amyloid-β plaque formation in a mouse model of Alzheimer's disease. Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Yang K; Chai Z; Zhao Y; Feng W Metallomics; 2012 Oct; 4(10):1113-8. PubMed ID: 22992540 [TBL] [Abstract][Full Text] [Related]
19. Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease. Timmer NM; Herbert MK; Kleinovink JW; Kiliaan AJ; De Waal RM; Verbeek MM Neuropathol Appl Neurobiol; 2010 Oct; 36(6):478-86. PubMed ID: 20831743 [TBL] [Abstract][Full Text] [Related]
20. Correlation of Aβ deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer's disease. Kameshima N; Nanjou T; Fukuhara T; Yanagisawa D; Tooyama I Neurosci Lett; 2012 Apr; 513(2):166-9. PubMed ID: 22343315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]